{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:39:51Z","timestamp":1790095191422,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":592,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007762","name":"Instituto Nacional de Ci\u00eancia e Tecnologia Translacional em Medicina","doi-asserted-by":"publisher","award":["465458\/2014-9"],"award-info":[{"award-number":["465458\/2014-9"]}],"id":[{"id":"10.13039\/501100007762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/24304-0"],"award-info":[{"award-number":["2017\/24304-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13311-021-01164-w","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T17:02:41Z","timestamp":1639414961000},"page":"434-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPAR\u03b3 Receptors"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-0776","authenticated-orcid":false,"given":"Nicole Rodrigues","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Isaac Fernandes","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Hashimoto Pereira","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora Lopes","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Cristina","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concei\u00e7\u00e3o Elidianne An\u00edbal","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Villela","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Mattar","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Silveira","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01164-w_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-021-01164-w_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1188\/07.CJON.901-913","article-title":"Putting Evidence Into Practice\u00ae: evidence-based interventions for chemotherapy-induced peripheral neuropathy","volume":"11","author":"Constance","year":"2007","journal-title":"Clin J Oncol Nurs"},{"key":"10.1007\/s13311-021-01164-w_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","article-title":"Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms?","volume":"596","author":"Carozzi","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-021-01164-w_bib4","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol Biol Cell"},{"key":"10.1007\/s13311-021-01164-w_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","article-title":"The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions","volume":"76","author":"Gornstein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/toxics3020198","article-title":"Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN)","volume":"3","author":"Canta","year":"2015","journal-title":"Toxics"},{"key":"10.1007\/s13311-021-01164-w_bib7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jpain.2016.02.011","article-title":"Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"J Pain"},{"key":"10.1007\/s13311-021-01164-w_bib8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/cr.2014.106","article-title":"Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter","volume":"24","author":"Liu","year":"2014","journal-title":"Cell Res"},{"key":"10.1007\/s13311-021-01164-w_bib9","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1158\/0008-5472.CAN-17-3480","article-title":"Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1 profile in a TLR4-dependent manner","volume":"78","author":"Wanderley","year":"2018","journal-title":"Cancer Res"},{"key":"10.1007\/s13311-021-01164-w_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","article-title":"Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy","volume":"291","author":"Jaggi","year":"2012","journal-title":"Toxicology"},{"key":"10.1007\/s13311-021-01164-w_bib11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","article-title":"Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain","volume":"10","author":"Sisignano","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1007\/s13311-021-01164-w_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells","volume":"203","author":"Peters","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1007\/s13311-021-01164-w_bib13","doi-asserted-by":"crossref","unstructured":"Siau C, Xiao W, Bennett GJ. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol. 2006;201:507\u2013514.","DOI":"10.1016\/j.expneurol.2006.05.007"},{"key":"10.1007\/s13311-021-01164-w_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1007\/s13311-021-01164-w_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","article-title":"Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy","volume":"37","author":"LaPointe","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1007\/s13311-021-01164-w_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4097\/kjae.2014.67.1.4","article-title":"Chemotherapy induced peripheral neuropathic pain","volume":"67","author":"Park","year":"2014","journal-title":"Korean J Anesthesiol"},{"key":"10.1007\/s13311-021-01164-w_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.npep.2014.02.001","article-title":"Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"48","author":"Ko","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1007\/s13311-021-01164-w_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2016.06.050","article-title":"Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy","volume":"333","author":"Duggett","year":"2016","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-021-01164-w_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1007\/s13311-021-01164-w_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejphar.2017.08.040","article-title":"Gabapentin and its salicylaldehyde derivative alleviate allodynia and hypoalgesia in a cisplatin-induced neuropathic pain model","volume":"814","author":"Ahmad","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.116.236182","article-title":"Palmitoylethanolamide reverses paclitaxel-induced allodynia in mice","volume":"359","author":"Donvito","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-021-01164-w_bib22","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","article-title":"Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram","year":"2017","journal-title":"Pain Physician"},{"key":"10.1007\/s13311-021-01164-w_bib23","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1007\/s13311-021-01164-w_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-003-1485-z","article-title":"Cannabinoids: reward, dependence, and underlying neurochemical mechanisms\u2014a review of recent preclinical data","volume":"169","author":"Tanda","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits neuropathic pain through 5-HT 1A receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1213\/ANE.0b013e3182283486","article-title":"Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice","volume":"113","author":"Ward","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1007\/s13311-021-01164-w_bib27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1055\/s-0042-106303","article-title":"Effects of delta-9-tetrahydrocannabinol and cannabidiol on cisplatin-induced neuropathy in mice","volume":"82","author":"Harris","year":"2016","journal-title":"Planta Med"},{"key":"10.1007\/s13311-021-01164-w_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pnpbp.2017.07.012","article-title":"Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative","volume":"79","author":"Silva","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-021-01164-w_bib29","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2005.09.121","article-title":"Novel time-dependent vascular actions of \u03949- tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma","volume":"337","author":"O'Sullivan","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-021-01164-w_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.pain.2008.06.003","article-title":"The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain : involvement of CB 1, TRPV1 and PPAR c receptors and neurotrophic factors","volume":"139","author":"Costa","year":"2008","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01164-w_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","article-title":"COX-2 and PPAR-\u03b3 confer cannabidiol-induced apoptosis of human lung cancer cells","volume":"12","author":"Ramer","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1007\/s13311-021-01164-w_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbi.2018.09.014","article-title":"Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPAR\u03b3 receptors","volume":"74","author":"Sonego","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1007\/s13311-021-01164-w_bib34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.steroids.2009.10.012","article-title":"Peroxisome proliferator-activated receptor gamma (PPAR\u03b3): is the genomic activity the only answer?","volume":"75","author":"Luconi","year":"2010","journal-title":"Steroids"},{"key":"10.1007\/s13311-021-01164-w_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00907","article-title":"Pharmacological treatment of chemotherapy-induced neuropathic pain: PPAR\u03b3 agonists as a promising tool","volume":"13","author":"Quint\u00e3o","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-021-01164-w_bib36","doi-asserted-by":"crossref","unstructured":"Luiz AP, MacDonald DI, Santana-Varela S, et al. Cold sensing by Na V 1.8-positive and Na V 1.8-negative sensory neurons. Proc Natl Acad Sci U S A. 2019;116:3811\u20133816.","DOI":"10.1073\/pnas.1814545116"},{"key":"10.1007\/s13311-021-01164-w_bib37","doi-asserted-by":"crossref","unstructured":"Dembo T, Braz JM, Hamel KA, et al. Primary afferent-derived BDNF contributes minimally to the processing of pain and itch. eNeuro. 2018;5:1\u201314.","DOI":"10.1523\/ENEURO.0402-18.2018"},{"key":"10.1007\/s13311-021-01164-w_bib38","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.4049\/jimmunol.1200495","article-title":"Systemic analysis of PPAR\u03b3 in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity","volume":"189","author":"Gautier","year":"2012","journal-title":"J Immunol"},{"key":"10.1007\/s13311-021-01164-w_bib39","first-page":"1","article-title":"Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects","volume":"11","author":"Breuer","year":"2016","journal-title":"PLoS One"},{"key":"10.1007\/s13311-021-01164-w_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuropharm.2017.02.020","article-title":"Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse","volume":"117","author":"Toma","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.03059","article-title":"IL-27 counteracts neuropathic pain development through induction of IL-10","volume":"10","author":"Fonseca","year":"2020","journal-title":"Front Immunol"},{"key":"10.1007\/s13311-021-01164-w_bib42","doi-asserted-by":"crossref","unstructured":"Foga\u00e7a MV, Campos AC, Coelho LD, Duman RS, Guimaraes FS. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. Neuropharmacology. 2018;135:22\u201333.","DOI":"10.1016\/j.neuropharm.2018.03.001"},{"key":"10.1007\/s13311-021-01164-w_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: an animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01164-w_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1590\/1414-431X20132894","article-title":"An interleukin-33\/ST2 signaling deficiency reduces overt pain-like behaviors in mice","volume":"46","author":"Magro","year":"2013","journal-title":"Brazilian J Med Biol Res"},{"key":"10.1007\/s13311-021-01164-w_bib45","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/bph.14473","article-title":"Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine","volume":"176","author":"Gobira","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20190613","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation","volume":"217","author":"Damasceno","year":"2020","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-021-01164-w_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1007\/s13311-021-01164-w_bib48","doi-asserted-by":"crossref","unstructured":"Singhmar P, Huo X, Li Y, Dougherty PM, Mei F, Cheng X, Heijnen CJ, Kavelaars A. An orally active Epac inhibitor reverses mechanical allodynia and loss of intraepidermal nerve fibers in a mouse model of chemotherapy-induced peripheral neuropathy. Pain. 2018;159:884\u2013893.","DOI":"10.1097\/j.pain.0000000000001160"},{"key":"10.1007\/s13311-021-01164-w_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-62429-6","article-title":"Combined chemo-magnetic field-photothermal breast cancer therapy based on porous magnetite nanospheres","volume":"10","author":"Sharifi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-021-01164-w_bib50","doi-asserted-by":"crossref","unstructured":"Abu-Serie MM, El-Fakharany EM. Efficiency of novel nanocombinations of bovine milk proteins (lactoperoxidase and lactoferrin) for combating different human cancer cell lines. Sci Rep. 2017;7:1\u201312.","DOI":"10.1038\/s41598-017-16962-6"},{"key":"10.1007\/s13311-021-01164-w_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1007\/s13311-021-01164-w_bib52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.108.141994","article-title":"Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats","volume":"327","author":"Rahn","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-021-01164-w_bib53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbi.2006.10.012","article-title":"Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats","volume":"21","author":"Ledeboer","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1007\/s13311-021-01164-w_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20122904","article-title":"Chemokine signaling in chemotherapy-induced neuropathic pain","volume":"20","author":"Brandolini","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-021-01164-w_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2013.00156","article-title":"Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)","volume":"4","author":"Han","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jphs.2019.02.007","article-title":"Indomethacin plus minocycline coadministration relieves chemotherapy and antiretroviral drug-induced neuropathic pain in a cannabinoid receptors-dependent manner","volume":"139","author":"Masocha","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1007\/s13311-021-01164-w_bib57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1213\/ANE.0b013e31821b220c","article-title":"The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development","volume":"113","author":"Takahashi","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1007\/s13311-021-01164-w_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbi.2021.05.002","article-title":"Regular swimming exercise prevented the acute and persistent mechanical muscle hyperalgesia by modulation of macrophages phenotypes and inflammatory cytokines via PPAR\u03b3 receptors","volume":"95","author":"de Azambuja","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1007\/s13311-021-01164-w_bib59","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1111\/jcmm.15427","article-title":"Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"24","author":"Kalynovska","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1007\/s13311-021-01164-w_bib60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","article-title":"Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1\u2013dependent withdrawal","volume":"77","author":"Deng","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-021-01164-w_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2010.09.004","article-title":"The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects","volume":"60","author":"Kinsey","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1254\/jphs.14134FP","article-title":"Establishment of opioid-induced rewarding effects under oxaliplatin- and paclitaxel-induced neuropathy in rats","volume":"126","author":"Mori","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"10.1007\/s13311-021-01164-w_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19113540","article-title":"Peroxisome proliferator-activated receptors (PPAR)\u03b3 agonists as master modulators of tumor tissue","volume":"19","author":"Heudobler","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-021-01164-w_bib65","first-page":"513","article-title":"Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review","volume":"23","author":"Chu","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1007\/s13311-021-01164-w_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib67","doi-asserted-by":"crossref","unstructured":"Starowicz K, Finn DP. Cannabinoids and pain: sites and mechanisms of action. 1st ed. Adv. Pharmacol. Elsevier Inc.; 2017.","DOI":"10.1016\/bs.apha.2017.05.003"},{"key":"10.1007\/s13311-021-01164-w_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-01062-2","article-title":"Inflammatory and neuropathic nociception is preserved in GPR55 knockout mice","volume":"7","author":"Carey","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-021-01164-w_bib69","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu Rev Neurosci"},{"key":"10.1007\/s13311-021-01164-w_bib70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/1570159X15666170911121027","article-title":"Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 receptors and their role in the modulation of pain response in the central nervous system","volume":"16","author":"Cortes-Altamirano","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12264-017-0200-8","article-title":"Regulation of pain and itch by TRP channels","volume":"34","author":"Moore","year":"2018","journal-title":"Neurosci Bull"},{"key":"10.1007\/s13311-021-01164-w_bib72","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1007\/s13311-021-01164-w_bib73","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor \u03b3 agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-021-01164-w_bib74","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2013.01.020","article-title":"PPAR\u03b3 activation blocks development and reduces established neuropathic pain in rats","volume":"70","author":"Morgenweck","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib75","doi-asserted-by":"crossref","unstructured":"Zanardelli M, Micheli L, Cinci L, et al. Oxaliplatin neurotoxicity involves peroxisome alterations. PPAR\u03b3 agonism as preventive pharmacological approach. PLoS One. 2014;9:1\u201315.","DOI":"10.1371\/journal.pone.0102758"},{"key":"10.1007\/s13311-021-01164-w_bib76","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/jnc.14827","article-title":"Crosstalk between Cdk5\/p35 and ERK1\/2 signalling mediates spinal astrocyte activity via the PPAR\u03b3 pathway in a rat model of chronic constriction injury","volume":"151","author":"Zhong","year":"2019","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-021-01164-w_bib77","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/j.pain.0000000000001448","article-title":"Pioglitazone, a PPARg agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress","volume":"160","author":"Khasabova","year":"2019","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01164-w_bib78","first-page":"1","article-title":"Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-021-01164-w_bib79","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/bph.14339","article-title":"PPARs and pain","volume":"176","author":"Okine","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-021-01164-w_bib80","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/156802612799436641","article-title":"General molecular biology and architecture of nuclear receptors","volume":"12","author":"Pawlak","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1007\/s13311-021-01164-w_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0170814","article-title":"Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy","volume":"12","author":"Makker","year":"2017","journal-title":"PLoS One"},{"key":"10.1007\/s13311-021-01164-w_bib82","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1101\/gad.312355.118","article-title":"PPAR\u03b3 is a nexus controlling alternative activation of macrophages via glutamine metabolism","volume":"32","author":"Nelson","year":"2018","journal-title":"Genes Dev"},{"key":"10.1007\/s13311-021-01164-w_bib83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clbc.2011.03.006","article-title":"Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach","volume":"11","author":"Carlson","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"10.1007\/s13311-021-01164-w_bib84","doi-asserted-by":"crossref","unstructured":"Belkouch M, Dansereau M, T\u00e9treault P, et al. Functional up-regulation of Nav 1. 8 sodium channel in A \u03b2 afferent fibers subjected to chronic peripheral inflammation. J Neuroinflammation. 2014;11:1\u201317.","DOI":"10.1186\/1742-2094-11-45"},{"key":"10.1007\/s13311-021-01164-w_bib85","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-021-01164-w_bib86","doi-asserted-by":"crossref","unstructured":"Klein AH, Vyshnevska A, Hartke TV, et al. Sodium channel Nav1.8 underlies TTX-resistant axonal action potential conduction in somatosensory C-fibers of distal cutaneous nerves. J Neurosci. 2017;37:5204\u20135214.","DOI":"10.1523\/JNEUROSCI.3799-16.2017"},{"key":"10.1007\/s13311-021-01164-w_bib87","doi-asserted-by":"crossref","unstructured":"Garrison SR, Weyer AD, Barabas ME, et al. A gain-of-function voltage-gated sodium channel 1.8 mutation drives intense hyperexcitability of A- and C-fiber neurons. Pain. 2014;155:896\u2013905.","DOI":"10.1016\/j.pain.2014.01.012"},{"key":"10.1007\/s13311-021-01164-w_bib88","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.45.10.1848","article-title":"Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy","volume":"45","author":"McCarthy","year":"1995","journal-title":"Neurology"},{"key":"10.1007\/s13311-021-01164-w_bib89","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","article-title":"A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel","volume":"94","author":"Polomano","year":"2001","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01164-w_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.009","article-title":"Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative","volume":"140","author":"Perez","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2009.06.004","article-title":"Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1-\/- and not CB2-\/- mice in models of acute and persistent pain","volume":"57","author":"Sain","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-021-01164-w_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.117.246215","article-title":"Repeated morphine produces sensitization to reward and tolerance to antiallodynia in male and female rats with chemotherapy-induced neuropathy","volume":"365","author":"Legakis","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-021-01164-w_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/13543784.2014.884708","article-title":"A new dawn for the use of thiazolidinediones in cancer therapy","volume":"23","author":"Joshi","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1007\/s13311-021-01164-w_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00031","article-title":"PPAR-\u03b3 agonists as antineoplastic agents in cancers with dysregulated IGF axis","volume":"8","author":"Vella","year":"2017","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01164-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01164-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01164-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:35:19Z","timestamp":1761806119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1878747923001794"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01164-w","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPAR\u03b3 Receptors","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01164-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}